K183088: ADVIA Centaur Erythropoietin (EPO) assay (FDA 510(k) & Recall Dossier)

U.S. FDA 510(k) Premarket Notification K183088 (ADVIA Centaur Erythropoietin (EPO) assay, cleared 2019-08-02 for Axis-Shield Diagnostics Limited) reconciled with CDRH recall records on Predicate Ledger.

Reconciled U.S. FDA 510(k) Premarket Notification Metadata for K183088
Regulatory FieldVerified FDA Record
FDA 510(k) NumberK183088
Cleared Device Trade / Generic NameADVIA Centaur Erythropoietin (EPO) assay
FDA Applicant on FilingAxis-Shield Diagnostics Limited
FDA 3-Letter Product ClassificationProduct Code GGT
FDA Substantial Equivalence Decision Date2019-08-02
De-Broadcasted Recall LinkageLinked to at least one historical or open CDRH/openFDA recall notice (1976 to 2026)

Inspect consolidated manufacturer lineage at Axis-Shield Diagnostics Limited, compare peer devices under FDA Product Code GGT, or browse all 20 FDA clinical specialties.

Meru AI Healthcare Data Engineering: Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI → · AI for Healthcare Practice · Healthcare Price & Patent-Cliff Crosswalk Guide.